151 related articles for article (PubMed ID: 9808091)
1. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
Ziswiler R; Steinmann-Niggli K; Kappeler A; Daniel C; Marti HP
J Am Soc Nephrol; 1998 Nov; 9(11):2055-66. PubMed ID: 9808091
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.
Steinmann-Niggli K; Ziswiler R; Küng M; Marti HP
J Am Soc Nephrol; 1998 Mar; 9(3):397-407. PubMed ID: 9513901
[TBL] [Abstract][Full Text] [Related]
3. Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis.
Suana AJ; Tuffin G; Frey BM; Knudsen L; Mühlfeld C; Rödder S; Marti HP
J Pharmacol Exp Ther; 2011 May; 337(2):411-22. PubMed ID: 21349934
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
6. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis.
Cantaluppi V; Medica D; Mannari C; Stiaccini G; Figliolini F; Dellepiane S; Quercia AD; Migliori M; Panichi V; Giovannini L; Bruno S; Tetta C; Biancone L; Camussi G
Nephrol Dial Transplant; 2015 Mar; 30(3):410-22. PubMed ID: 25488895
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.
Hauser IA; Renders L; Radeke HH; Sterzel RB; Goppelt-Struebe M
Nephrol Dial Transplant; 1999 Jan; 14(1):58-63. PubMed ID: 10052478
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.
Chiara M; Menegatti E; Di Simone D; Davit A; Bellis D; Sferch D; De Rosa G; Giachino O; Sena LM; Roccatello D
Clin Exp Immunol; 2005 Feb; 139(2):225-35. PubMed ID: 15654821
[TBL] [Abstract][Full Text] [Related]
10. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.
Yung S; Zhang Q; Zhang CZ; Chan KW; Lui SL; Chan TM
Arthritis Rheum; 2009 Jul; 60(7):2071-82. PubMed ID: 19565476
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolic acid antagonizes the activation of cultured human mesangial cells.
Dubus I; Vendrely B; Christophe I; Labouyrie JP; Delmas Y; Bonnet J; Combe C
Kidney Int; 2002 Sep; 62(3):857-67. PubMed ID: 12164867
[TBL] [Abstract][Full Text] [Related]
12. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wagner A; Stasch JP; Hugo C
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney.
Badid C; Vincent M; McGregor B; Melin M; Hadj-Aissa A; Veysseyre C; Hartmann DJ; Desmouliere A; Laville M
Kidney Int; 2000 Jul; 58(1):51-61. PubMed ID: 10886549
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
16. Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis.
Nieto E; Escudero E; Navarro E; Yáñez-Mo M; Martín A; Pérez de Lema G; Sánchez-Madrid F; Mampaso F
J Am Soc Nephrol; 2002 Apr; 13(4):937-945. PubMed ID: 11912253
[TBL] [Abstract][Full Text] [Related]
17. Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.
Hackl A; Ehren R; Weber LT
Pediatr Nephrol; 2017 Aug; 32(8):1315-1322. PubMed ID: 27312386
[TBL] [Abstract][Full Text] [Related]
18. Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells.
Morath C; Zeier M
Int J Clin Pharmacol Ther; 2003 Oct; 41(10):465-9. PubMed ID: 14703952
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells.
Sabuda-Widemann D; Grabensee B; Schwandt C; Blume C
Nephrol Dial Transplant; 2009 Jan; 24(1):52-61. PubMed ID: 18723570
[TBL] [Abstract][Full Text] [Related]
20. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
